| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2021 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BRIACELL THERAPEUTICS CORP | 8 | Q3 2023 | 26.0% |
| AMERICAS GOLD AND SILVER COR | 8 | Q3 2023 | 9.5% |
| INSPIRA TECHNOLOGIES OXY BHN | 8 | Q3 2023 | 1.7% |
| CINGULATE INC | 8 | Q3 2023 | 0.0% |
| CHAVANT CAPITAL ACQUISITN CO | 8 | Q3 2023 | 0.0% |
| PEARL HOLDINGS ACQUISITN COR | 7 | Q3 2023 | 3.6% |
| TARGET GLOBAL ACQUISI I CORP | 7 | Q3 2023 | 4.0% |
| TARGET GLOBAL ACQUISI I CORP | 7 | Q3 2023 | 2.1% |
| ROTH CH ACQUISITION V CO | 7 | Q3 2023 | 2.1% |
| PEARL HOLDINGS ACQUISITN COR | 7 | Q3 2023 | 1.9% |
View Lynwood Capital Management Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BriaCell Therapeutics Corp. | February 14, 2023 | 1,460,000 | 9.3% |
View Lynwood Capital Management Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-01 |
| 13F-HR | 2023-08-14 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-10-25 |
| 13F-HR | 2022-08-02 |
| SC 13G | 2022-08-01 |
View Lynwood Capital Management Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.